Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Morreau, H.
(-)
= Kapiteijn, E.
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(13)
+
-
Availability
Open access
(3)
+
-
Metadata Only
(10)
+
-
Creation Date
2012
(5)
+
-
2019
(3)
+
-
Faculty
Leiden University Medical Center (LUMC)
(12)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(12)
+
-
Topic
AKT
(2)
+
-
cell signaling
(2)
+
-
humans
(2)
+
-
targeted therapy
(2)
+
-
thyroid cancer
(2)
+
-
Author
Morreau, H.
(13)
+
-
Wezel, T. van
(10)
+
-
Schneider, T.C.
(6)
+
-
Smit, J.W.A.
(6)
+
-
Corver, W.E.
(5)
+
-
Aydemirli, M.D.
(4)
+
-
Gelderblom, H.
(4)
+
-
Eijk, R. van
(3)
+
-
Hoeven, J.J.M. van der
(3)
+
-
Links, T.P.
(3)
+
-
Oosting, J.
(3)
+
-
Beuk, R.
(2)
+
-
Corver, W.
(2)
+
-
Erp, N.P. van
(2)
+
-
Guchelaar, H.J.
(2)
+
-
Hovens, G.
(2)
+
-
Jordanova, E.S.
(2)
+
-
Middeldorp, A.
(2)
+
-
Miranda, N. de
(2)
+
-
Nieuwenhuizen, M.P. van
(2)
+
-
Nortier, J.W.R.
(2)
+
-
Roepman, P.
(2)
+
-
Ruano, D.
(2)
+
-
Smit, J.
(2)
+
-
Solleveld-Westerink, N.
(2)
+
-
Tuin, K. van der
(2)
+
-
Weijers, K.
(2)
+
-
Wit, D. de
(2)
+
-
Show more
Language
en
(13)
+
-
Search results
(1 - 13 of 13)
show grid
show list
save search
Targeting EML4-ALK gene fusion variant 3 in thyroid cancer
A unique case of two somatic APC mutations in an early onset cribriform-morular variant of papillary thyroid carcinoma and overview of the literature
Targeted treatment options of recurrent radioactive iodine refractory Hürthle cell cancer
Targeted Treatment Options of Recurrent Radioactive Iodine Refractory Hurthle Cell Cancer
Targetable gene fusions identified in radioactive iodine refractory advanced thyroid carcinoma
Everolimus in Patients With Advanced Follicular-Derived Thyroid Cancer: Results of a Phase II Clinical Trial
(Secondary) solid tumors in thyroid cancer patients treated with the multi-kinase inhibitor sorafenib may present diagnostic challenges
Beneficial Effects of the mTOR Inhibitor Everolimus in Patients with Advanced Medullary Thyroid Carcinoma: Subgroup Results of a Phase II Trial
Long-term analysis of the efficacy and tolerability of sorafenib in advanced radio-iodine refractory differentiated thyroid carcinoma: final results of a phase II trial
Genome Haploidisation with Chromosome 7 Retention in Oncocytic Follicular Thyroid Carcinoma
Distinct chromosomal alterations in oncocytic follicular thyroid carcinoma
New treatment modalities in advanced thyroid cancer
New treatment modalities in advanced thyroid cancer